Research News
View articles by month and year
11–20 of 32 articles
-
Circulating Tumor Cells Linked to Worse Prognosis
New studies suggest that even one circulating tumor cell in a blood sample from a woman diagnosed with breast cancer is linked to a worse prognosis.
-
Link Between Obesity and Worse Prognosis Isn’t Consistent
The analysis of several studies show the link between obesity and worse prognosis in women diagnosed with early-stage breast cancer isn't consistent.
-
Breast Cancer Survival Triples in Last 60 Years
During the past 60 years, the average number of women who survived for 10 years after being diagnosed with breast cancer and treated at the University of Texas MD Anderson Cancer Center tripled.
-
Genomic Test Results Not Understood by Many Women
A small study found that about a third of women who had genomic testing didn't really understand the test results.
-
Aspirin Seems to Improve Prognosis
Research suggests that premenopausal women who took two or more aspirin each week in the years after a diagnosis of early-stage breast cancer have a better prognosis than women who don't take aspirin.
-
Even Small HER2-Positive Cancers Have Higher Recurrence Risk
Small (1 cm or smaller), early-stage, HER2-positive breast cancers are more likely to come back (recur) and spread to parts of the body away from the breast (metastasize) than small, early-stage HER2-negative breast cancers, which suggests that treating these cancers with Herceptin (chemical name: trastuzumab) may make sense.
-
Lymph Node Ultrasound Before Surgery Can Help Find Cancer Spread
Ultrasound of underarm lymph nodes can determine if cancer has spread to those lymph nodes in some cases.
-
Isolated Cancer Cells in Lymph Nodes Need Treatment After Surgery
Women diagnosed with node-negative, early-stage breast cancer -- but with isolated cancer cells in the sentinel lymph node -- were 56% less likely to survive without the breast cancer coming back in the 5 years after treatment compared to women who were truly node negative (no cancer cells at all in the sentinel lymph node). This suggests that women diagnosed with isolated cancer cells in the sentinel node should be treated as if the cancer is node-positive.
-
Women Treated for Hormone-Receptor-Negative Cancers More Likely to be Diagnosed with New Cancer in Other Breast
Research shows that women treated for hormone-receptor-negative breast cancer are more than 3 times more likely to be diagnosed with a new cancer (either hormone-receptor-positive or -negative) in the other breast compared to women treated for hormone-receptor-positive breast cancer.
-
New Guidelines for Early-Stage Breast Cancer Recommend Treatment Based on Individual Cancer Characteristics
A large group of cancer experts created new guidelines for treating early-stage breast cancer; the guidelines recommend that chemotherapy, targeted therapies, radiation therapy, and hormonal therapy should be based on the characteristics of each individual cancer being treated.
11–20 of 32 articles
